Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination
Authors
Keywords
-
Journal
EBioMedicine
Volume 89, Issue -, Pages 104475
Publisher
Elsevier BV
Online
2023-03-02
DOI
10.1016/j.ebiom.2023.104475
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
- (2022) Alexandra C. Walls et al. CELL
- Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
- (2022) Yunlong Cao et al. NATURE
- Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
- (2022) Victoria Hall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Homologous and Heterologous Covid-19 Booster Vaccinations
- (2022) Robert L. Atmar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants
- (2022) Timothy A. Bates et al. Science Immunology
- Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine
- (2022) Rishi R. Goel et al. CELL
- Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2
- (2022) John P. Evans et al. Cell Host & Microbe
- Current evidence on efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review
- (2022) Santenna Chenchula et al. JOURNAL OF MEDICAL VIROLOGY
- Broad anti–SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination
- (2022) Chengzi I. Kaku et al. SCIENCE
- Waning of SARS-CoV-2 booster viral-load reduction effectiveness
- (2022) Matan Levine-Tiefenbrun et al. Nature Communications
- Introduction and transmission of SARS-CoV-2 lineage B.1.1.7, Alpha variant, in Denmark
- (2022) Thomas Y. Michaelsen et al. Genome Medicine
- Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
- (2022) Ulrika Marking et al. Vaccines
- Potent SARS-CoV-2 Neutralizing Antibodies Directed Against Spike N-Terminal Domain Target a Single Supersite
- (2021) Gabriele Cerutti et al. Cell Host & Microbe
- Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection
- (2021) Jan Van Elslande et al. JOURNAL OF CLINICAL VIROLOGY
- Overcoming culture restriction for SARS-CoV-2 in human cells facilitates the screening of compounds inhibiting viral replication
- (2021) Santseharay Ramirez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
- (2021) Kanika Vanshylla et al. Cell Host & Microbe
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
- (2021) N. Ahmad Aziz et al. Nature Communications
- In vitro data suggest that Indian delta variant B.1.617 of SARS‐CoV‐2 escapes neutralization by both receptor affinity and immune evasion
- (2021) Gilles Augusto et al. ALLERGY
- Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
- (2021) Dami A. Collier et al. NATURE
- Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
- (2021) Jia Wei et al. Nature Microbiology
- Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals
- (2021) Alena J. Markmann et al. mSphere
- Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19
- (2021) Alexander P. Underwood et al. EBioMedicine
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
- (2021) Hiam Chemaitelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants
- (2021) Rüdiger Groß et al. EBioMedicine
- Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera
- (2021) Takuya Tada et al. iScience
- Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
- (2021) Deborah Cromer et al. Lancet Microbe
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
- (2020) Philip J. M. Brouwer et al. SCIENCE
- Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
- (2020) Sabra L. Klein et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
- (2020) Etienne Brochot et al. Frontiers in Microbiology
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Restricted Clonality and Limited Germinal Center Reentry Characterize Memory B Cell Reactivation by Boosting
- (2019) Luka Mesin et al. CELL
- Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
- (2017) Matthias Pauthner et al. IMMUNITY
- Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination
- (2016) Hok Hei Tam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity
- (2015) Joyce K. Hu et al. JOURNAL OF VIROLOGY
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
- (2008) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now